Methotrexate for sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 15, Issue 2, 1998, Pages 147-149

  Baughman, Robert P ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Corticosteroids; Cytotoxic drugs; Therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYTOTOXIC AGENT; METHOTREXATE;

DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG SARCOIDOSIS; LUNG TOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME;

BIOPSY; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; LUNG DISEASES; METHOTREXATE; SAFETY; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 0031715956     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Lacher MJ: Spontaneous remission response to methotrexate in sarcoidosis. Ann Intern Med 1968; 69: 1274-1278.
2. Israel HL: The treatment of sarcoidosis. Postgrad Med J 1970; 46: 537-540.
3. Webster GF, Razsi LK, Sanchez M, Shupack JL: Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991; 24: 451-154.
4. Henderson CA, Ilchyshyn A, Curry AR: Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med 1994; 87: 632-633.
5. Rajendran R, Theertham M, Salgia R, Mulhuswamy P: Methotrexate in the treatment of cutaneous sarcoidosis. Sarcoidosis 1994; 11: S335-S338.
6. Pia G, Pascalis L, Aresu G, Rosetti L, Ledda MA: Evaluation of the efficacy and toxicity of the cyclosporine A-fluocorolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 146-152.
7. Neville E, Walker AN, James DG: Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. QJ Med 1983; 208: 525-533.
8. Rizzato G, Fraioli P, Montemurro L: Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 1995; 50: 555-559.
9. Johns CJ, Zachary JB, Ball WC: A ten year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med 1974; 134: 271-283.
10. Lynch JPI, Mc Cune WJ: Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997; 155: 395-420.
11. Williams HJ, Wilkens RF, Samuelson CO et al: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1985; 28: 721-730.
12. Anderson PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis. Ann Intern Med 1985; 103: 489-496.
13. Lower EE, Baughman RP: The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990; 299: 153-157.
14. Lower EE, Baughman RP: Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155: 846-851.
15. Hu SK, Mitcho YL, Oronsky AL, Kerwar SS: Studies on the effect of methotrexate on macrophage function. J Rheumatol 1988; 15: 206-209.
16. Baughman RP, Strohofer SA, Buchsbaum J, Louer EE: Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990; 115; 36-42.
17. Kaneshima H, Nagai S, Shimoji T et al: TNF alpha MRNA, but not IL-1 beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis. Sarcoidosis 1994; 11: 19-25.
18. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW: The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest 1993; 103: 832-838.
19. Baughman RP, Lower EE: The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142: 1268-1271.
20. Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 121-130.
21. Tolman KG, Clegg DO, Lee, RG, Ward JR: Methotrexate and the liver. J Rheumatol 1985; 12: S29-S34.
22. Browne PM, Sharma OP, Salkin D: Bone marrow sarcoidosis JAMA 1978; 240: 43-50.
23. Lower EE, Smith JT, Martelo OJ, Baughman RP: The anemia of sarcoidosis. Sarcoidosis 1988; 5: 51-55.
24. Morgan SL, Bagott JE, Vaughn WH et al: Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. Ann Intern Med 1994; 121: 833-841.
25. Wallace CA, Smith AL, Sherry DD: Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis. J Rheumatol 1993; 20: 1764-1768.
26. Sostman HD, Matthay RA, Putman GE: Methotrexate-induced pneumonitis - Medicine 1976; 55: 371-388.
27. Hargreaves MR, Mowat AG, Benson MK: Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 1992; 47: 628-633.